Table 3.
Risk factors of SRBD in patients with MSA.
| OR (95%CI) | |||
|---|---|---|---|
| Model 1 | Model 2 | Model 3 | |
| UMSARS | 1.01 (0.97–1.06)* | 1.02 (0.97–1.07)* | 1.02 (0.97–1.08)* |
| NMSS | 1.00 (0.98–1.02)* | 1.00 (0.97–1.02)* | 1.00 (0.97–1.03)* |
| HAMA | 1.02 (0.95–1.10)* | 1.03 (0.95–1.11)* | 1.04 (0.95–1.13)* |
| HAMD | 1.05 (0.97–1.13)* | 1.05 (0.95–1.14)* | 1.05 (0.96–1.15)* |
| MMSE | 1.09 (0.95–1.26)* | 1.10 (0.95–1.28)* | 1.10 (0.93–1.29)* |
| PSQI | 0.94 (0.82–1.08)* | 0.94 (0.82–1.07)* | 0.96 (0.83–1.12)* |
| FSS | 0.94 (0.92–1.01)* | 0.97 (0.92–1.02)* | 0.96 (0.91–1.01)* |
CI, confidence interval; FSS, Fatigue Severity Scale; HAMD, Hamilton Depression Scale; HAMA, Hamilton Anxiety Scale; MMSE, Mini-mental State Examination; NMSS, Non-Motor Symptoms Scale.
Model 1, Crude model; Model 2, Adjusted for age, sex; Model 3, Adjusted for age, sex, disease duration, smoking, alcohol consumption, and MSA sub-type. *p > 0.05.